Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Matthew J. Freeby"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Type 2 diabetes mellitus (T2DM) patients show brain tissue changes in mood and cognitive regulatory sites, but the nature and extent of tissue injury and their associations with symptoms are unclear. Our aim was to examine brain tissue damag
Externí odkaz:
https://doaj.org/article/daccf26199fa4f30be6fae862af280e1
Publikováno v:
Current Opinion in Endocrinology, Diabetes & Obesity. 29:29-33
Hemoglobin A1c testing provides a marker of glycemic control and is the standard for diabetes risk assessment. According to the Centers for Disease Control (CDC), only 67.3-71.4% of diabetic patients between 2011 and 2016 had at least two A1c levels
Autor:
Kyrstin L. Lane, Matthew J. Freeby
Publikováno v:
Current Opinion in Endocrinology, Diabetes & Obesity. 28:8-13
Purpose of review Insulin is the mainstay of treatment in people living with type 1 diabetes mellitus due to an immune-mediated loss of beta cells. Yet despite advances in insulin therapy and other technological advances, glycemic control remains dif
Autor:
Cristina Cabrera-Mino, Matthew J. Freeby, Rajesh Kumar, Mary A. Woo, Bhaswati Roy, Sarah E. Choi
Publikováno v:
Sleep Vigil
BACKGROUND: Poor sleep is common in adults with Type 2 Diabetes Mellitus (T2DM), which may contribute to brain tissue changes. However, the impact of sleep quality on brain tissue in T2DM individuals is unclear. We aimed to evaluate differential slee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406eff225cc8865a75179f1c0b0471b2
https://europepmc.org/articles/PMC8887871/
https://europepmc.org/articles/PMC8887871/
Autor:
Mary A. Woo, Sarah E. Choi, Rajesh Kumar, Luke Ehlert, Bhaswati Roy, Rashmi S. Mullur, Matthew J. Freeby
Publikováno v:
Scientific Reports
Scientific reports, vol 10, iss 1
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific reports, vol 10, iss 1
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Patients with Type 2 diabetes mellitus (T2DM) show cognitive and mood impairment, indicating potential for brain injury in regions that control these functions. However, brain tissue integrity in cognition, anxiety, and depression regulatory sites, a
Publikováno v:
Journal of the Endocrine Society
Calcium sulfate beads are used to fill bone voids in bone loss and nonunion, as well as in the management of bone and joint infections.1 Specifically, Stimulan® is an absorbed form of antibiotic-loaded calcium sulfate beads which delivers high local
Publikováno v:
J Diabetes
BACKGROUND This study examined brain tissue integrity in sites that controls cognition (prefrontal cortices; PFC) and its relationships to glycemic outcomes in adults with type 2 diabetes mellitus (T2DM). METHODS We examined 28 T2DM patients (median
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b60f309f0081c863a567f86693515ba4
https://europepmc.org/articles/PMC7210044/
https://europepmc.org/articles/PMC7210044/
Autor:
Matthew J. Freeby, Yijun Chen, Erik Dutson, Emily Huang, Linda Liu, Yen-Yi Juo, Vanessa Arguello
Publikováno v:
Surgery for Obesity and Related Diseases. 14:1246-1253
Metabolic surgery remains underutilized despite its efficacy and safety. Poor perception of surgery has been cited as one of the major reasons.Evaluate current patient perceptions about metabolic surgery and measure the impact a video-based education
Autor:
Matthew J. Freeby, Vanessa Arguello
Publikováno v:
Annals of internal medicine. 167(6)
The editorialists discuss the findings, what we know about the benefits of CGM in patients with type 1 diabetes, and the potential role of CGM in selected patients with type 2 diabetes in light of ...
Autor:
Rudolph L. Leibel, Paul L. Harris, Robin Goland, Matthew J. Freeby, Antonella Maffei, Masanori Ichise, Patricia Kringas, Chaitan Divgi
Publikováno v:
Molecular imaging and biology (2015). doi:10.1007/s11307-015-0888-7
info:cnr-pdr/source/autori:Freeby MJ, Kringas P, Goland RS, Leibel RL, Maffei A, Divgi C, Ichise M, Harris PE./titolo:Cross-sectional and Test-Retest Characterization of PET with [18F]FP-(+)-DTBZ for ? Cell Mass Estimates in Diabetes./doi:10.1007%2Fs11307-015-0888-7/rivista:Molecular imaging and biology/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Molecular Imaging and Biology
info:cnr-pdr/source/autori:Freeby MJ, Kringas P, Goland RS, Leibel RL, Maffei A, Divgi C, Ichise M, Harris PE./titolo:Cross-sectional and Test-Retest Characterization of PET with [18F]FP-(+)-DTBZ for ? Cell Mass Estimates in Diabetes./doi:10.1007%2Fs11307-015-0888-7/rivista:Molecular imaging and biology/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Molecular Imaging and Biology
Purpose The vesicular monoamine transporter, type 2 (VMAT2) is expressed by insulin producing β cells and was evaluated as a biomarker of β cell mass (BCM) by positron emission tomography (PET) with [18F]fluoropropyl-dihydrotetrabenazine ([18F]FP-(